First-line immunotherapy does not improve survival in metastatic lung cancer Single or combination first-line immunotherapy does not significantly extend survival compared with chemotherapy in metastatic non small-cell lung carcinoma, trial results have shown.…
Pembrolizumab extends survival in recurrent head and neck cancer A study of nearly 500 patients with head and neck cancers reveals that pembrolizumab could extend survival compared with methotrexate, docetaxel or cetuximab, which are the standard of care.…
Androgen deprivation therapy ‘increases heart failure risk’ Patients with prostate cancer treated with androgen deprivation therapy were 72% more likely to experience heart failure than those unexposed to the therapy, a study has shown.…
NHS patients waiting longer for new cancer drugs Patients are waiting almost a year and a half longer for new cancer drugs to be made available on the NHS than they were a decade ago, a report from the Institute of Cancer Research has found.…
Project to sequence 100,000 genomes from NHS patients hits target The 100,000 Genomes Project has reached its goal to sequence 100,000 genomes from NHS patients by the end of 2018, Matt Hancock, health and social care secretary, has announced.…
ACEIs linked to increased risk of lung cancer An observational study of almost one million people suggests a link between angiotensin converting enzyme inhibitors and an increased risk of lung cancer.…
Low-dose aspirin cuts ovarian cancer risk Use of low-dose aspirin is associated with a reduced risk of ovarian cancer, results from a cohort study show.…
Durvalumab increases overall survival in stage III non-small-cell lung cancer The immune checkpoint inhibitor durvalumab significantly improves survival in people with stage III non-small-cell lung cancer, interim trial results published in The New England Journal of Medicine have shown.…
Newer hormonal contraceptives still associated with reduced risk of ovarian cancer Researchers in Denmark found that newer combined hormonal contraceptives were still associated with a reduction in ovarian cancer risk in women of reproductive age.…
Healthcare professionals uncertain about promoting e-cigarettes to patients with cancer who smoke, study finds Nearly 30% of healthcare professionals would not recommend e-cigarettes to patients with cancer who smoke, a study has found.…